Americans are facing the highest death toll from influenza since 2018, just as more people become vulnerable because of growing vaccine skepticism taking hold in statehouses and the Trump ...

To the Editor, The clock is ticking for Rhode Island. In February, the FDA cancelled its annual meeting to pick which flu strains should go into next winter’s flu shot. The virus changes ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...